Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome.

dc.contributor.author	Hancer, VS
dc.contributor.author	Inanc, Murat
dc.contributor.author	Nalcaci, M
dc.contributor.author	Pekcelen, Y
dc.contributor.author	Diz-Kucukkaya, R
dc.date.accessioned	2021-03-05T11:05:36Z
dc.date.available	2021-03-05T11:05:36Z
dc.identifier.citation	Diz-Kucukkaya R., Hancer V., Inanc M., Nalcaci M., Pekcelen Y., "Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome.", 45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102
dc.identifier.other	vv_1032021
dc.identifier.other	av_a6726fe3-c6aa-437d-873b-9c854765b1c4
dc.identifier.uri	http://hdl.handle.net/20.500.12627/111310
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Hematoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	HEMATOLOJİ
dc.title	Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome.
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	102
dc.contributor.firstauthorID	129210

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.